TrialBritish journal of cancer2004

Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safety.

E Baldini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.